Selank (10 mg Vial) Dosage Protocol
Quickstart Highlights
Selank is a synthetic heptapeptide analog of tuftsin with demonstrated anxiolytic and anti-asthenic (energy-boosting) properties in human clinical trials[1][2]. In Russian studies, intranasal Selank produced anxiolytic effects comparable to benzodiazepines without sedation or dependence potential[1]. This educational protocol presents a once‑daily subcutaneous approach using practical dilution for accurate insulin‑syringe measurements.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 300 mcg (0.3 mg) | 9 units (0.09 mL) |
| Weeks 3–4 | 500 mcg (0.5 mg) | 15 units (0.15 mL) |
Frequency: Inject once daily subcutaneously[3]. A common cycling pattern is 4 weeks on, 4 weeks off to prevent tachyphylaxis, though continuous daily use has been studied in clinical trials for up to 14 days with good tolerability[2]. Some practitioners recommend administering 5 days per week with 2-day breaks[3].
For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.
Reconstitution Steps
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week protocol with 4-week cycles and gradual titration.
- 8 weeks (one 4-week cycle) ≈ 2 vials
- 12 weeks (1.5 cycles) ≈ 4 vials
- 16 weeks (two complete cycles) ≈ 5 vials
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
- 8 weeks (2 vials): 6 mL → 1 × 10 mL bottle
- 12 weeks (4 vials): 12 mL → 2 × 10 mL bottles
- 16 weeks (5 vials): 15 mL → 2 × 10 mL bottles
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
- 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
- 16 weeks: 224 swabs → recommend 3 × 100‑count boxes
Protocol Overview
Concise summary of the once‑daily anxiolytic/nootropic regimen.